Literature DB >> 26563882

Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models.

Cristina P R Xavier, Milica Pesic, M Helena Vasconcelos1.   

Abstract

Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26563882     DOI: 10.2174/1568009616666151113120705

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  11 in total

1.  The Cellosaurus, a Cell-Line Knowledge Resource.

Authors:  Amos Bairoch
Journal:  J Biomol Tech       Date:  2018-05-10

2.  Hyperphosphorylation of HDAC2 promotes drug resistance in a novel dual drug resistant mouse melanoma cell line model: an in vitro study.

Authors:  Bhuvanesh Sukhlal Kalal; Prashant Kumar Modi; Mohd Altaf Najar; Santosh Kumar Behera; Dinesh Upadhya; Thottethodi Subrahmanya Keshava Prasad; Vinitha Ramanath Pai
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity.

Authors:  Cao Guo; Ping Liu; Ganlu Deng; Ying Han; Yihong Chen; Changjing Cai; Hong Shen; Gongping Deng; Shan Zeng
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

4.  Exploring effects of DNA methylation and gene expression on pan-cancer drug response by mathematical models.

Authors:  Wenhua Lv; Xingda Zhang; Huili Dong; Qiong Wu; Baoqing Sun; Yan Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-28

5.  Special Issue: New Approaches to Counteract Drug Resistance in Cancer.

Authors:  M Helena Vasconcelos
Journal:  Molecules       Date:  2016-12-23       Impact factor: 4.411

6.  An optical study of drug resistance detection in endometrial cancer cells by dynamic and quantitative phase imaging.

Authors:  Tian Yao; Runyu Cao; Wen Xiao; Feng Pan; Xiaoping Li
Journal:  J Biophotonics       Date:  2019-04-02       Impact factor: 3.207

7.  Different Ability of Multidrug-Resistant and -Sensitive Counterpart Cells to Release and Capture Extracellular Vesicles.

Authors:  Diana Sousa; Raquel T Lima; Vanessa Lopes-Rodrigues; Esperanza Gonzalez; Félix Royo; Cristina P R Xavier; Juan M Falcón-Pérez; M Helena Vasconcelos
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 8.  Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.

Authors:  Srijit Das; Norsham Juliana; Noor Anisah Abu Yazit; Sahar Azmani; Izuddin Fahmy Abu
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

9.  Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer.

Authors:  Kha Wai Hon; Nurul Syakima Ab-Mutalib; Nik Muhd Aslan Abdullah; Rahman Jamal; Nadiah Abu
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

10.  Chemical Characterization and Biological Evaluation of New Cobalt(II) Complexes with Bioactive Ligands, 2-Picolinehydroxamic Acid and Reduced Schiff Base N-(2-Hydroxybenzyl)alanine, in Terms of DNA Binding and Antimicrobial Activity.

Authors:  Magdalena Woźniczka; Marta Lichawska; Manas Sutradhar; Magdalena Chmiela; Weronika Gonciarz; Marek Pająk
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.